The global industrial microbiology market has reached a valuation of USD 15.49 billion in 2023, with a projected CAGR of 7.6% from 2023 to 2033. By 2033, the market is anticipated to reach USD 32.12 billion.
With advancements in biotechnology, genetic engineering, and microbial cultivation techniques, the market offers a plethora of opportunities for industries to optimize their operations, enhance product quality, and reduce environmental impact. Given that fermentation applications are gaining popularity in syrup formulations, the market is anticipated to register rising demand in the pharmaceutical & biotechnology sector.
| Attributes | Details |
|---|---|
| Industrial Microbiology Market Estimated Value (2023) | USD 15.49 billion |
| Industrial Microbiology Market Estimated Value (2033) | USD 32.12 billion |
| Industrial Microbiology Market Value CAGR (2023 to 2033) | 7.6% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The market for industrial microbiology secured a CAGR of 7.5% from 2018 to 2022 owing to the expansion of the pharmaceutical industry and increasing preference for automation, which are in turn bolstering the adoption of sterility testing within the pharmaceutical industry.
As per FMI, increasing adoption of testing procedures within the food & beverage industry is expected to bolster the market growth over the forecast period. Due to the growing demand for consumer products and the rise in the population worldwide, the adoption of sterility testing for product quality and safety testing is surging.
Emphasis on industrial safety and food & hygiene is likely to improve the demand over the coming years. Moreover, the rising application of industrial microbiology within agriculture, food & beverages, cosmetics, and pharmaceutical industries is also expected to open up a wide array of opportunities in the market.
The consumption of prescription antibiotics continues to increase the adoption of industrial microbiology among generic drug makers, despite the threat of rising anti-microbial drug resistance, especially across India and China.
The demand for industrial microbiology is set to expand at 7.6% CAGR during the assessment period from 2023 to 2033 based on the factors contributing to the market.
Focus on process automation of traditional industrial methods, aimed at reducing overall cost of production quite is likely to aid the expansion of the market further.
The United States of America is quite likely to lead North America’s industrial microbiology market over the forecast period, where North America held a value share of 27.8% in 2022.
The expansion of the pharmaceutical & biotechnology industry has paved the way for increased adoption of sterility testing across the country. Moreover, increased research & development activities in the field of the pharmaceutical industry along with drug discovery have propelled the industrial microbiology market growth.
Industrial microbiology applications across the United States of America are gaining popularity in the pharmaceutical excipients industry. The significantly growing food & beverage industry has also boosted the growth of industrial microbiology.
The increasing usage of microorganisms in the syrup formulations has improved the adoption of sterility as well as bio-burden testing. Further, the rising drug development and growing demand for pathogen testing in food products have significantly improved growth opportunities.
Stringent regulatory frameworks associated with anti-microbial food additives and favorable policies supporting the adoption of sterility testing have accelerated the demand for industrial microbiology, especially within the food & beverage industry. For instance,
In a 2020 report of the USA Food and Drug Administration for pharmaceutical microbiology, the government made it mandatory to go through a sterility and bio-burden test to examine the toxicity level of a drug or additive.
The United States of America market is expected to post substantial gains over the forecast period with a value share of 21.4% in 2022 on a global level, with the rapid adoption of sterility testing within the food & beverage industry,
The expansion of the biopharmaceutical industry and increasing adoption of sterility testing within the pharmaceutical & food and beverage industry have improved the demand for industrial microbiology.
As per Future Market Insights, China is expected to be the notable market, accounting for a significant share in the global industrial microbiology industry, and is likely to secure a 7.6% CAGR from 2023 to 2033.
With the growing population and rising disposable income, the demand for consumer products is expected to surge, which requires safety and quality testing of the products. Hence, increased adoption of sterility and bio-burden testing within the pharmaceutical industry can improve the demand.
Favorable government regulations and growing public concerns about the products’ safety are likely to accelerate the growth of China’s industrial microbiology market over the coming years.
Surging research and development activities within the pharmaceutical industry across India have improved the market demand for industrial microbiology, facilitating the country’s projected growth rate of 7.2% from 2023 to 2033.
The rising population and increasing demand for consumer products such as food additives and growing drug discovery push forward the adoption of sterility testing within the pharmaceutical and food & beverage industry.
The development and production of products rich in hyaluronic acid within dermatology applications have boosted revenue growth. Moreover, favorable regulatory policies and increasing investment from the government in research & development activities bolster the market growth during the forecast period.
Spiking healthcare spending and expansion of the pharmaceutical industry create growth opportunities. Furthermore, leading companies in the industrial microbiology market are shifting their production base with research & development activities across India for industrial microbiology applications due to additional benefits such as low labor, production, and land cost.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
In terms of product type, the market is segmented into equipment & systems, reaction consumables, and others. As per FMI’s analysis, reaction consumables acquired a market share of 61.07% in 2022.
The soaring usage of reagents in the research and development activities on drug delivery is likely to improve the segment as well as market growth. Besides this, application in the biotechnological industry has improved the adoption of automated equipment and microbial detection systems.
Filtration pumps & systems, and air monitoring systems are extensively adopted, thereby improving the segment’s growth, with the rise in drug-related discovery in the pharmaceutical industry,
Sterility test type in industrial microbiology plays an important role in the food & beverage and pharmaceutical industries for quality check of products. Further, with extensive adoption of sterility tests in the pharmaceutical and food & beverages industry, the segment is expected to witness high demand over the forecast period.
Bio-burden, environment, and water tests are conducted on a large scale in the pharmaceutical industries. Moreover, industrial microbiology applications such as bio-burden tests are performed for aerobic or anaerobic organism testing, which is prompting growth within the segment. With the bio-pharmaceutical industry witnessing an upsurge, the adoption of sterility and bio-burden testing has gained prevalence.
By the FMI study, the sterility test type garnered a value share of 34.21% in 2022 on a global level.
Future Market Insights have sub-segmented the end user segment into pharmaceuticals & biotechnology, food & beverages, agriculture & environmental, and personal care products. As per the study, the pharmaceutical & biotechnology segment is anticipated to witness high growth during the forecast period and accounted for 51.7% market share in 2022.
The uptick in research & development activities within the pharmaceutical industry related to industrial microbiology has augmented over the years and is expected to propel in the future. As per the report by the Association of British Pharmaceutical Industry (ABPI), increased investment in research & development activities aimed at developing industrial microbiology products has increased the expenditure on healthcare.
As per ABPI, the pharmaceutical industry invested around USD 156.7 billion in 2016 and is expected to invest more in the upcoming years, accelerating market growth.
With a few top tier-1 players such as Thermo Fisher Scientific Inc., Merck KGaA, and BioMerieuxx dominating the market, the market is consolidated in nature, opines market study by FMI.
As per the study, the market for industrial microbiology is almost monopolistic with leading players expanding their existing wide product portfolio to maintain their lead in the industry.
These leading players have a strong presence and hold a significant market share in the industrial microbiology industry.
Their extensive product portfolios, technological advancements, and robust distribution networks contribute to their market dominance. However, the market also offers opportunities for small players to enter niche segments and cater to specific customer requirements, fostering competition and innovation within the industry.
Strategic mergers and acquisitions are sought-after among top healthcare companies. Stringent government regulations thwart the entry of new players, making the top players dominant in the industry. Leading players are relying on new product launches and other inorganic strategies to generate large revenues.
Developments in the Market:
The global market is forecasted to develop at an impressive 7.6% CAGR until 2033.
The total demand for in the United States alone accounted for 27.8% of the global market share in 2022.
China is likely to secure 7.6% CAGR through 2033 followed by India at 7.2% CAGR.
The pharmaceutical and biotechnology segment generated almost 51.7% of the total demand in 2022.
The reaction consumables acquired nearly 61% of the global market share in 2022.
| Estimated Year Value (2023E) | USD 32,729.05 million |
|---|---|
| Projected Year Value (2033F) | USD 56,974.87 million |
| Value CAGR (2023 to 2033) | 5.7% |
| Estimated Market Value (2022) | USD 3.7 Billion |
|---|---|
| Projected Market Value (2032) | USD 10.7 Billion |
| Value-based CAGR (2022 to 2032) | 11.3% |
Explore Life Science & Biotechnology Insights
View Reports
Industrial Microbiology Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
